CIPO Patents = 3

EPO Patents = 7

Forward Citations = 3

Loading Chart...

10 inventors (with patents filed for the assignee):

Stephan Ludwig (4 out of 7 patents)

Oliver Planz (3 out of 4 patents)

Christina Ehrhardt (2 out of 3 patents)

4. Stephan Pleschka (1 out of 2 patents)

5. Michael Schindler (1 patent)

6. Julia Koch-heier (0 patent)

7. Helen Elisa Hoffmann (0 patent)

8. Sascha Rohn (0 patent)

9. Peer Riehle (0 patent)

10. Carmen Hartmayer (0 patent)

5 patents: Sort by Forward Citations

1. 12350244 - MEK-inhibitor for the treatment of viral and bacterial infections (2025-07-08),

2. 11903917 - MEK-inhibitor for the treatment of viral and bacterial infections (2024-02-20),

3. 11135263 - Novel-anti-infective strategy against influenza virus andcoinfections (2021-10-05),

4. 10456440 - Anti-infective strategy against influenza virus andcoinfections (2019-10-29),

5. 9566281 - MEK inhibitors in the treatment of virus diseases (2017-02-14),

Atriva Therapeutics is a biopharmaceutical company focusing on the development of small molecule antiviral treatments. Leveraging their innovative drug discovery platform, they aim to combat viral infections and improve patient outcomes. With a strong pipeline of novel antiviral compounds, Atriva Therapeutics is dedicated to addressing unmet medical needs in infectious diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

5 Patents

#8 in Tuebingen

#6,008 in Germany

Tuebingen, Germany

Atriva Therapeutics Gmbh

Forward Citations = 3

10 inventors:

Stephan Ludwig (4 out of 7 patents)

Oliver Planz (3 out of 4 patents)

Christina Ehrhardt (2 out of 3 patents)

4. Stephan Pleschka (1 out of 2 patents)

5. Michael Schindler (1 patent)

Please report any incorrect information to support@idiyas.com

3 patents (CIPO):

Please report any incorrect information to support@idiyas.com

7 patents (EPO):

Please report any incorrect information to support@idiyas.com